Boston Scientific Corporation vs Impinj Inc — how do they compare? Boston Scientific Corporation trades at $51.05 (market cap $74.19B), while Impinj Inc trades at $177.62 (market cap $5.32B). The key difference: Boston Scientific Corporation is far larger — about 13.9× Impinj Inc's market cap, and Impinj Inc is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | PI | |
|---|---|---|
Market Cap | $74.19B | $5.32B |
Sector | Health | Technology |
52-Week High | $108.14 | $241.91 |
52-Week Low | $42.63 | $91.34 |
Enterprise Value | $86.27B | $5.45B |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →